No Controversy Here

While controversy exists in the USA concerning research with embryonic stem cells, everyone agrees that using adult stem cells are appropriate and efficacious. Rabin Medical Center has made a major breakthrough in applying adult stem cells to treat Parkinson's disease by developing NurOwn, a technology that generates neuron-like cells derived from human bone marrow. Using the patient's own bone marrow to supply dopamineproducing cells circumvents problems of immunity and compatibility. Credit for the discovery goes to Prof. Eldad Melamed, Director of Neurology at the Rabin Medical Center and member of the Michael J. Fox Foundation for Parkinson's Research, together with Dr. Daniel Offen, Director of Laboratory of Neurosciences at Rabin Medical Center, and Dr. Yosef Levy. Commercialized by Brainstorm Cell Therapeutics based in Tel Aviv, NurOwn actually produces the missing chemical that enables restoration of motor movement.

Related Articles

Strange Brew: Caffeine and Blood Thinners?


What happens when caffeine and Plavix (a common blood thinning medication used by heart patients) come together?


read more »

The Earlier the Better: Probing Malignancies in Newborns


Building on their established international partnership, GE Healthcare and Rabin Medical Center are developing innovative products and working on creative medical solutions to facilitate the early diagnosis of medical problems in pregnant women and their fetuses.


read more »

Staying Strong During Cancer


As if being stricken with cancer isn't enough, there are many cancer patients whose immune systems become so weakened by chemotherapy treatments that they become prone to life threatening infections.


read more »